Chen et al. [32] found that the levels of autoantibody against fascin in the patients with esophageal squamous carcinoma (ESCC) were significantly higher than in control subjects, even for early-stage ESCC. The gene discussed is FSCN1; the disease is esophageal squamous cell carcinoma.